Catalyst Crew Technologies Corp. (OTC: CCTC), an artificial intelligence-driven healthcare technology company focused on scalable digital health solutions for emerging markets, announced that its Chief Executive Officer, Kevin Roldan Levy, has initiated a capital structure initiative. Under the plan, up to fifty percent (50%) of Levy's restricted common stock holdings are expected to be canceled in exchange for a newly designated class of preferred equity.
The initiative is intended to support the Company's broader capital structure objectives, including optimization of its common equity base, enhancement of long-term strategic flexibility, and alignment of executive equity participation with broader corporate development goals. Management believes that, upon implementation, the transaction is expected to contribute to a more disciplined equity framework and support the Company's evolving long-term strategic initiatives, including future financing opportunities, strategic partnerships, and broader operational development.
This capital structure initiative is also expected to strengthen alignment between executive leadership and long-term corporate performance objectives while reinforcing management's commitment to disciplined growth and shareholder-oriented development. "This initiative reflects my long-term commitment to the Company's strategic development and disciplined capital structure management," said Kevin Roldan Levy. "As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation."
The Company is currently finalizing the structure and designation of the new preferred equity as part of the implementation process and expects to provide additional updates as final corporate actions are completed. Catalyst Crew continues to advance its transition into AI-enabled healthcare, with a focus on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets.
Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.
For more information, please visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
